...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: My New Year's wish if for RVX to get a deal structured similarly to MYOV...

Well, this is how "The Market Herald" recaps it. (Dec 23, 2020)

"Resverlogix (TSX: RVX) posts promising COVID-19 treatment findings."

https://themarketherald.ca/resverlogix-announces-apabetalone-treatment-prior-to-sars-cov-2-covid-19-exposure-significantly-reduces-viral-infection-confirms-plans-for-covid-19-clinical-trial-2020-12-23/?utm_source=stockhouse.com&utm_medium=widget&utm_campaign=stockhouse.com%7Cwebpart_news%7Cnews_tab

Question for the scientists:

Would apabetalone be prophylactic or therapeutic?     Or both?

 

Koo

Share
New Message
Please login to post a reply